Search for:

Search Medicine or Company Name Search Full Document

Advanced Search

Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA

Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 21/09/2011

SPC	Germolene Antiseptic Ointment

Table of Contents

1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
4.2 Posology and method of administration
4.3 Contraindications
4.4 Special warnings and precautions for use
4.5 Interaction with other medicinal products and other forms of interaction
4.6 Pregnancy and lactation
4.7 Effects on ability to drive and use machines
4.8 Undesirable effects
4.9 Overdose
5. PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
5.2 Pharmacokinetic properties
5.3 Preclinical safety data
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
6.2 Incompatibilities
6.3 Shelf life
6.4 Special precautions for storage
6.5 Nature and contents of container
6.6 Special precautions for disposal and other handling
Administrative Data
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT

Go to top of the page

1. NAME OF THE MEDICINAL PRODUCT

Germolene Antiseptic Ointment

Go to top of the page

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Zinc Oxide Ph. Eur. 6.55%, Methyl Salicylate Ph. Eur. 3%, Phenol Ph. Eur. 1.19% and Octafonium Chloride 0.3%.

Go to top of the page

3. PHARMACEUTICAL FORM

Ointment for topical administration.

Go to top of the page

4. CLINICAL PARTICULARS

Go to top of the page

4.1 Therapeutic indications

For minor cuts and grazes, minor burns and scalds and blisters, sore or rough skin, wash-day hands, sunburn and the symptomatic relief of muscular pain and stiffness.

Go to top of the page

4.2 Posology and method of administration

Minor cuts and grazes etc.: Clean the wound and apply directly or on a dressing.

Minor burns, scalds and blisters: Apply liberally and cover with a light bandage.

Sore, rough skin, wash-day hands, sunburn etc.: Apply directly and rub in gently.

Stiff, aching muscles: Apply liberally and massage in thoroughly.

Go to top of the page

4.3 Contraindications

Hypersensitivity to any of the ingredients.

Go to top of the page

4.4 Special warnings and precautions for use

For external use only.

Keep out of the reach of children.

If symptoms persist, consult your doctor.

Go to top of the page

4.5 Interaction with other medicinal products and other forms of interaction

None known.

Go to top of the page

4.6 Pregnancy and lactation

Use in pregnancy and lactation is not contraindicated. However, as with all medicines during pregnancy, caution should be exercised.

Go to top of the page

4.7 Effects on ability to drive and use machines

None.

Go to top of the page

4.8 Undesirable effects

Local allergic reactions may occur. Very rarely, contact dermatitis may occur.

Go to top of the page

4.9 Overdose

It is very unlikely that overdose would occur with this pharmaceutical form. Theoretically, frequently repeated topical application on the same site could lead to skin irritation. However, since the product is only intended for minor skin trauma, extensive exposure is unlikely.

Go to top of the page

5. PHARMACOLOGICAL PROPERTIES

Go to top of the page

5.1 Pharmacodynamic properties

Zinc oxide is a mild astringent. Methyl salicylate is a topical analgesic and anti-inflammatory. Phenol is an antiseptic and local anaesthetic. Octafonium chloride is an antiseptic. Wool fat, yellow soft paraffin, white soft paraffin, light liquid paraffin and starch all have emollient properties.

Go to top of the page

5.2 Pharmacokinetic properties

Not applicable.

Go to top of the page

5.3 Preclinical safety data

There are no preclinical data of any relevance additional to that already included in other sections of the SmPC.

Go to top of the page

6. PHARMACEUTICAL PARTICULARS

Go to top of the page

6.1 List of excipients

Wool fat

Yellow soft paraffin